Heart failure drug treatment: the fantastic four
Author:
Affiliation:
1. Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/42/6/681/36241209/ehaa1012.pdf
Reference16 articles.
1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC);Ponikowski;Eur J Heart Fail,2016
2. The treatment of heart failure with reduced ejection fraction;Berliner;Dtsch Arztebl Int,2020
3. Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis;Komajda;Eur J Heart Fail,2018
4. DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019
5. EMPEROR Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020
Cited by 172 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Renal arterial resistance index before and after vericiguat administration: Should it be considered the fantastic five?;International Journal of Cardiology;2024-11
2. Pharmacological and Device-Based Intervention for Preventing Heart Failure After Acute Myocardial Infarction ― A Clinical Review ―;Circulation Journal;2024-09-13
3. A Trajetória das Gliflozinas: Da Casca da Macieira à Redução de Mortalidade Total na Insuficiência Cardíaca;ABC Heart Failure & Cardiomyopathy;2024-09-06
4. The Trajectory of Gliflozins: From Apple Tree Bark to Reduced Overall Mortality in Heart Failure;ABC Heart Fail Cardiomyop;2024-09
5. Implementation and evaluation of pharmacist-led heart failure diagnostic and guideline directed medication therapies clinic;International Journal of Clinical Pharmacy;2024-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3